InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: SocialBoom post# 237711

Monday, 12/30/2019 7:59:01 AM

Monday, December 30, 2019 7:59:01 AM

Post# of 426436
S-

the 12 week argument dies in the language stating as an add on to maximum tolerated statin. Statins are lifelong drugs. Period. End of story

Please note: the subject (language) in the current litigation is:

is an ethyl ester of eicosapentaenoic acid (EPA) indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia

The "as an adjunct to maximally tolerated statin therapy" is not.

Part of the patent claim / process:

Applicant claims a method of treating patients having triglycerides (TG) levels between 500 mg/dl and 1500 mg/dl (very high) which are not receiving any concurrent lipid altering therapy (like statins)

Best,
G

"There are some things money can't buy. … For these, there is AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News